剂泰科技-P今日盘中股价大幅下挫，跌幅达到7.10%，市场表现引人关注。
消息面上，剂泰科技作为全球AI药物递送第一股，于近期登陆港交所，上市首日曾录得显著涨幅。然而，新股热度正逐渐消退，股价自高点持续回调。公司目前仍处于商业化早期阶段，过去三年累计亏损约15亿元，营收表现波动，未来业绩增长前景尚需时间验证。
此外，有市场分析指出，该股部分国际配售股份未设置禁售期，上市后存在一定的获利了结压力，这也是导致股价承压回落的重要因素之一。
剂泰科技-P今日盘中股价大幅下挫，跌幅达到7.10%，市场表现引人关注。
消息面上，剂泰科技作为全球AI药物递送第一股，于近期登陆港交所，上市首日曾录得显著涨幅。然而，新股热度正逐渐消退，股价自高点持续回调。公司目前仍处于商业化早期阶段，过去三年累计亏损约15亿元，营收表现波动，未来业绩增长前景尚需时间验证。
此外，有市场分析指出，该股部分国际配售股份未设置禁售期，上市后存在一定的获利了结压力，这也是导致股价承压回落的重要因素之一。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.